ABSCI CORP Acquisitions, Net of Cash Acquired
ABSCI CORP (ABSI) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2024-03-21
- ABSCI CORP payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $0.00.
- ABSCI CORP payments to acquire businesses, net of cash acquired for the quarter ending 2023-09-30 was $0.00.
- ABSCI CORP payments to acquire businesses, net of cash acquired for the quarter ending 2022-12-31 was $0.00.
- ABSCI CORP payments to acquire businesses, net of cash acquired for the quarter ending 2022-09-30 was $0.00.
- ABSCI CORP payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ABSCI CORP payments to acquire businesses, net of cash acquired for fiscal 2022 was $8.00M, a 71.56% decline from fiscal 2021.
- ABSCI CORP payments to acquire businesses, net of cash acquired for fiscal 2021 was $28.13M.
- ABSCI CORP payments to acquire businesses, net of cash acquired for fiscal 2020 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $8.00M derived: sum of 3 quarters · filed 2024-03-21 | $8.00M 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $8.00M derived: sum of 2 quarters · filed 2023-11-14 | $8.00M 10-Q · filed 2023-11-14 | $8.00M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $8.00M 10-Q · filed 2023-08-14 | $8.00M derived: sum of 3 quarters · filed 2023-08-14 | $8.00M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $25.62M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $25.62M derived: sum of 3 quarters · filed 2023-03-30 | $28.13M 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $25.62M derived: sum of 2 quarters · filed 2022-11-09 | $28.13M 10-Q · filed 2022-11-09 | $28.13M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $25.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $28.13M 10-Q · filed 2022-08-11 | $28.13M derived: sum of 3 quarters · filed 2022-08-11 | $28.13M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.51M 10-Q · filed 2022-05-11 | $2.51M derived: sum of 2 quarters · filed 2022-05-11 | $2.51M derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $0.00 derived: sum of 2 quarters · filed 2022-03-22 | $0.00 10-K · filed 2022-03-22 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |